BIOSPECIFICS TECHNOLOGIES CORP Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for the quarter ending 2020-06-30 was $191.73K, a 61.71% increase year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for the quarter ending 2020-03-31 was $221.03K.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for the quarter ending 2019-12-31 was $263.36K, a 40.30% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for fiscal 2019 was $620.65K, a 79.31% decline from fiscal 2018.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for fiscal 2018 was $3.00M, a 386.65% increase from fiscal 2017.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for fiscal 2017 was $616.50K, a 41.21% decline from fiscal 2016.
- BIOSPECIFICS TECHNOLOGIES CORP treasury stock, value, acquired, cost method for fiscal 2016 was $1.05M, a 41.82% decline from fiscal 2015.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $676.12K derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | $191.73K 10-Q · filed 2020-08-10 | $914.85K derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-03-31 | $221.03K 10-Q · filed 2020-05-11 | $841.68K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-12-31 | $263.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $620.65K 10-K · filed 2020-03-16 |
| 2019-09-30 | $238.72K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $118.57K 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $441.13K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $3.00M 10-K · filed 2020-03-16 |
| 2018-09-30 | $2.56M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $616.50K 10-K · filed 2019-04-02 | |
| 2016-12-31 | $1.05M 10-K · filed 2019-04-02 | |
| 2015-12-31 | $1.80M 10-K · filed 2018-03-14 | |
| 2014-12-31 | $829.61K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $674.87K 10-K · filed 2016-03-14 | |
| 2012-12-31 | $1.03M 10-K · filed 2015-03-16 | |
| 2011-12-31 | $739.55K 10-K · filed 2014-03-07 | |
| 2010-12-31 | $458.00K 10-K · filed 2013-03-15 |